Cannabis Stocks Rise On Breaking Senate Cannabis News
Cannabis stocks rose Thursday after Bloomberg reported that Senate Democrats plan to introduce legislation decriminalizing the popular and widespread plant’s use.
The report said Senate Majority Leader Chuck Schumer and fellow democrats Cory Booker and Ron Wyden planned to introduce the Cannabis Administration and Opportunity Act.
Why Investors With ESG In Mind Might Want To Rethink Investing In ESG Funds
In 2021, the impact of environmental, social and governance (ESG) issues became of much greater importance for investors. Inflows into ESG funds continued to increase last year, with inflows for the first three quarters surpassing those recorded for all of 2020, which amounted to $51.1 billion. By the end of 2021, inflows to ESG funds.
Q2 2022 hedge fund letters, conferences and more
That sent weed stocks across the US and Canada higher with welcome relief after widespread losses that halved share prices across the sector this year.
The bill would exclude cannabis from the federal controlled substances list and include measures to reform the criminal justice system.
The trio drafted a preliminary bill last year and has amended it following broader Senate input.
Earlier this year, the Democrat-controlled US House of Representatives passed ‘The Marijuana Opportunity Reinvestment and Expungement Act’ to legalize cannabis at the federal level.
The bill needs sixty Senate votes to pass and head to President Biden’s desk
Piper Sandler & Co analyst Michael Lavery believes the bill is already dead on arrival. The Democrats control less than the required sixty votes, and few Republican senators would back the bill. They note that two Democrats have already criticized the proposed law.
Lavery said that’s bill’s timing and details aren’t yet fully formed.
Canaccord Genuity’s Matt Bottomley saw the bill’s progress as hampered by its proximity to the November midterm elections and politicians’ known aversion to voting for anything people will remember.
Even so, Bottomley believes significant institutional funds are waiting for regulatory clarity before firing up their investment in the sector.
Tilray Inc (NASDAQ:TLRY) is the 23rd most popular stock among retail investors linking their portfolios with Fintel for free. That’s up three places from Wednesday.
This week Tilray said shareholders approved its HEXO acquisition on July 5. It said the two expect the combination will save them $80 in operating costs over the next two years.
Tilray’s Fintel’s bullish 0.31 put/call ratio suggests a positive options market, and the graph below illustrates open call interest more than doubling put interest in the stock.
Fintel’s options flow data show Thursday’s call options volume following the Senate news.
Cannabis Stocks Rise On Breaking Senate Cannabis News
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
